These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 2963084

  • 1. Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG.
    Rada EM, Convit J, Ulrich M, Gallinotto ME, Aranzazu N.
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):646-50. PubMed ID: 2963084
    [Abstract] [Full Text] [Related]

  • 2. Lymphocyte response of leprosy patients to human-derived and purified armadillo-derived Mycobacterium leprae, BCG and PPD.
    Smelt AH, Liew FY, Rees RJ.
    Clin Exp Immunol; 1978 Nov; 34(2):164-9. PubMed ID: 367652
    [Abstract] [Full Text] [Related]

  • 3. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients.
    Brett SJ, Kingston AE, Colston MJ.
    Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217
    [Abstract] [Full Text] [Related]

  • 4. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E, Ulrich M, Aranzazu N, Santaella C, Gallinoto M, Centeno M, Rodriguez V, Convit J.
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test.
    Job CK, Chacko CJ, Taylor PM, Daniel M, Jesudian G.
    Int J Lepr Other Mycobact Dis; 1976 Dec; 44(1-2):256-66. PubMed ID: 776862
    [Abstract] [Full Text] [Related]

  • 6. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).
    Rada E, Ulrich M, Aranzazu N, Rodriguez V, Centeno M, Gonzalez I, Santaella C, Rodriguez M, Convit J.
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484
    [Abstract] [Full Text] [Related]

  • 7. Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts.
    Convit J, Aranzazu N, Ulrich M, Pinardi ME, Reyes O, Alvarado J.
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):415-24. PubMed ID: 6763002
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Histologic responses in sixty multibacillary leprosy patients inoculated with autoclaved Mycobacterium leprae and live BCG.
    Meyers WM, McDougall AC, Fleury RN, Neves R, Reyes O, Binford CH.
    Int J Lepr Other Mycobact Dis; 1988 Jun; 56(2):302-9. PubMed ID: 3045226
    [Abstract] [Full Text] [Related]

  • 10. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
    Laal S, Mishra RS, Nath I.
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors.
    Mohagheghpour N, Gelber RR, Engleman EG.
    J Immunol; 1987 Jan 15; 138(2):570-4. PubMed ID: 2947952
    [Abstract] [Full Text] [Related]

  • 13. Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy.
    Sengupta U, Sinha S, Ramu G, Lamb J, Ivanyi J.
    Clin Exp Immunol; 1987 Apr 15; 68(1):58-64. PubMed ID: 3308210
    [Abstract] [Full Text] [Related]

  • 14. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR, Janson AM, Thole JE, Buhrer S, Bos C, Soebono H, de Vries RR.
    Int J Lepr Other Mycobact Dis; 1997 Jun 15; 65(2):178-89. PubMed ID: 9251589
    [Abstract] [Full Text] [Related]

  • 15. Immunization against leprosy: progress and prospects.
    Noordeen SK, Sansarricq H.
    Bull World Health Organ; 1984 Jun 15; 62(1):1-6. PubMed ID: 6370487
    [Abstract] [Full Text] [Related]

  • 16. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS.
    Int J Lepr Other Mycobact Dis; 1996 Sep 15; 64(3):257-67. PubMed ID: 8862259
    [Abstract] [Full Text] [Related]

  • 17. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N, Gelber RH, Larrick JW, Sasaki DT, Brennan PJ, Engleman EG.
    J Immunol; 1985 Aug 15; 135(2):1443-9. PubMed ID: 2989366
    [Abstract] [Full Text] [Related]

  • 18. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
    Bapat CV, Modak MS, DeSouza NG, Chulawalla RG.
    Lepr India; 1977 Oct 15; 49(4):472-84. PubMed ID: 342823
    [Abstract] [Full Text] [Related]

  • 19. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ, Baskin GB, Xu K, Ratterree MS, Mack PA, Bohm RP, Meyers WM, Walsh GP.
    Lepr Rev; 2002 Sep 15; 73(3):254-61. PubMed ID: 12449891
    [Abstract] [Full Text] [Related]

  • 20. Immunotherapy and immunoprophylaxis of leprosy.
    Convit J, Ulrich M.
    Indian J Lepr; 2000 Sep 15; 72(1):21-32. PubMed ID: 10935184
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.